Stocks and Investing
Stocks and Investing
Mon, July 31, 2023
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
[ Mon, Jul 31st 2023
] - WOPRAI
A.J. Rice Reiterated (ACHC) at Buy and Held Target at $95 on, Jul 31st, 2023
A.J. Rice of Credit Suisse, Reiterated "Acadia Healthcare Company, Inc." (ACHC) at Buy and Held Target at $95 on, Jul 31st, 2023.
A.J. has made no other calls on ACHC in the last 4 months.
There are 4 other peers that have a rating on ACHC. Out of the 4 peers that are also analyzing ACHC, 1 agrees with A.J.'s Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $83 on, Wednesday, July 12th, 2023
These are the ratings of the 3 analyists that currently disagree with A.J.
- Andrew Mok of "UBS" Maintained at Strong Buy with Decreased Target to $88 on, Friday, July 28th, 2023
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, April 28th, 2023
- Pito Chickering of "Deutsche Bank" Downgraded from Hold to Strong Sell and Decreased Target to $63 on, Thursday, April 20th, 2023
Contributing Sources